How Mexico revolutionized the science of antivenom Innovative policies and a diverse scorpion population have led to new treatments in Mexico, providing a model for other developing countries, experts say. PUEBLA STATE, MEXICO Ojo de Agua Ranch, at the edge of the sleepy town of Agua Fria, is home to nine dogs, six geese, 12 canaries, 21 sheep, and 163 horses. The sprawling 400-acre oasis is the inheritance of five brothers, the eldest of which, Alejandro Alagón, bought the equines in 2008 with a specific purpose in mind: Creating antivenom. Nearly 140,000 people die from snakebites annually, many of which are treatable with antivenoms, according to the World Health Organization. Envenomations—the term for bites and stings caused by animals such as snakes and scorpions—are also a silent scourge: In 2017, WHO added snakebite envenomations to its list of neglected tropical diseases. That’s why, throughout the 20th century, Mexican researchers improved and invented over a dozen antivenoms now used in the U.S. and elsewhere. Today, Mexican antivenoms are marketed through the country’s three biggest antivenom firms, Instituto Bioclon, BIRMEX, and Inosan Biopharma, which supplies the U.S. military.